KALA BIO, INC. Increase (Decrease) in Accrued Liabilities
KALA BIO, INC. (KALA) reported Increase (Decrease) in Accrued Liabilities of -$1.11 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-19
- KALA BIO, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was -$117.00K.
- KALA BIO, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$995.00K.
- KALA BIO, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was -$1.31M, a 278.40% decline year-over-year.
- KALA BIO, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was -$984.00K.
- KALA BIO, INC. increase (decrease) in accrued liabilities for fiscal 2025 was -$3.89M.
- KALA BIO, INC. increase (decrease) in accrued liabilities for fiscal 2024 was -$1.53M.
- KALA BIO, INC. increase (decrease) in accrued liabilities for fiscal 2023 was -$2.42M.
- KALA BIO, INC. increase (decrease) in accrued liabilities for fiscal 2022 was -$11.93M, a 795.80% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$117.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | -$1.11M 10-Q · filed 2026-08-19 | -$2.42M derived: sum of 3 quarters · filed 2026-08-19 | -$3.41M derived: sum of 4 quarters · filed 2026-08-19 | ||
| 2026-03-31 | -$995.00K 10-Q · filed 2026-05-15 | -$2.31M derived: sum of 2 quarters · filed 2026-05-15 | -$3.29M derived: sum of 3 quarters · filed 2026-05-15 | -$4.01M derived: sum of 4 quarters · filed 2026-08-19 | ||
| 2025-12-31 | -$1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$2.30M derived: sum of 2 quarters · filed 2026-04-15 | -$3.01M derived: sum of 3 quarters · filed 2026-08-19 | -$3.89M 10-K · filed 2026-04-15 | ||
| 2025-09-30 | -$984.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$1.70M derived: sum of 2 quarters · filed 2026-08-19 | -$2.58M 10-Q · filed 2025-11-19 | -$1.84M derived: sum of 4 quarters · filed 2026-08-19 | ||
| 2025-06-30 | -$715.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | -$1.60M 10-Q · filed 2026-08-19 | -$860.00K derived: sum of 3 quarters · filed 2026-08-19 | -$2.10M derived: sum of 4 quarters · filed 2026-08-19 | ||
| 2025-03-31 | -$881.00K 10-Q · filed 2026-05-15 | -$145.00K derived: sum of 2 quarters · filed 2026-05-15 | -$1.39M derived: sum of 3 quarters · filed 2026-05-15 | -$245.00K derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | $736.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$506.00K derived: sum of 2 quarters · filed 2026-04-15 | $636.00K derived: sum of 3 quarters · filed 2026-04-15 | -$1.53M 10-K · filed 2026-04-15 | ||
| 2024-09-30 | -$1.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$100.00K derived: sum of 2 quarters · filed 2025-11-19 | -$2.26M 10-Q · filed 2025-11-19 | -$4.37M derived: sum of 4 quarters · filed 2025-11-19 | ||
| 2024-06-30 | $1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$1.02M 10-Q · filed 2025-08-08 | -$3.13M derived: sum of 3 quarters · filed 2025-08-08 | $1.21M derived: sum of 4 quarters · filed 2025-08-08 | ||
| 2024-03-31 | -$2.16M 10-Q · filed 2025-05-14 | -$4.27M derived: sum of 2 quarters · filed 2025-05-14 | $65.00K derived: sum of 3 quarters · filed 2025-05-14 | -$97.00K derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | -$2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $2.23M derived: sum of 2 quarters · filed 2025-03-31 | $2.07M derived: sum of 3 quarters · filed 2025-03-31 | -$2.42M 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $4.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $4.17M derived: sum of 2 quarters · filed 2024-11-12 | -$319.00K 10-Q · filed 2024-11-12 | -$16.78M derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | -$162.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$4.65M 10-Q · filed 2024-08-06 | -$21.11M derived: sum of 3 quarters · filed 2024-08-06 | -$13.91M derived: sum of 4 quarters · filed 2024-08-06 | ||
| 2023-03-31 | -$4.49M 10-Q · filed 2024-05-14 | -$20.95M derived: sum of 2 quarters · filed 2024-05-14 | -$13.74M derived: sum of 3 quarters · filed 2024-05-14 | -$16.74M derived: sum of 4 quarters · filed 2024-05-14 | ||
| 2022-12-31 | -$16.46M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$9.26M derived: sum of 2 quarters · filed 2024-03-29 | -$12.25M derived: sum of 3 quarters · filed 2024-03-29 | -$11.93M 10-K · filed 2024-03-29 | ||
| 2022-09-30 | $7.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $4.21M derived: sum of 2 quarters · filed 2023-11-13 | $4.53M 10-Q · filed 2023-11-13 | $5.75M derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | -$3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$2.67M 10-Q · filed 2023-08-04 | -$1.45M derived: sum of 3 quarters · filed 2023-08-04 | -$2.92M derived: sum of 4 quarters · filed 2023-08-04 | ||
| 2022-03-31 | $326.00K 10-Q · filed 2023-05-09 | $1.54M derived: sum of 2 quarters · filed 2023-05-09 | $74.00K derived: sum of 3 quarters · filed 2023-05-09 | $5.86M derived: sum of 4 quarters · filed 2023-05-09 | ||
| 2021-12-31 | $1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | -$252.00K derived: sum of 2 quarters · filed 2023-03-03 | $5.54M derived: sum of 3 quarters · filed 2023-03-03 | $1.71M 10-K · filed 2023-03-03 | ||
| 2021-09-30 | -$1.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $4.32M derived: sum of 2 quarters · filed 2022-11-08 | $495.00K 10-Q · filed 2022-11-08 | $3.61M derived: sum of 4 quarters · filed 2022-11-08 | ||
| 2021-06-30 | $5.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $1.97M 10-Q · filed 2022-08-11 | $5.08M derived: sum of 3 quarters · filed 2022-08-11 | $6.99M derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | -$3.82M 10-Q · filed 2022-05-16 | -$703.00K derived: sum of 2 quarters · filed 2022-05-16 | $1.20M derived: sum of 3 quarters · filed 2022-05-16 | $438.00K derived: sum of 4 quarters · filed 2022-05-16 | ||
| 2020-12-31 | $3.12M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $5.02M derived: sum of 2 quarters · filed 2022-03-29 | $4.26M derived: sum of 3 quarters · filed 2022-03-29 | -$1.76M 10-K · filed 2022-03-29 | ||
| 2020-09-30 | $1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $1.14M derived: sum of 2 quarters · filed 2021-11-15 | -$4.88M 10-Q · filed 2021-11-15 | $1.29M derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | -$759.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$6.78M 10-Q · filed 2021-08-05 | -$606.00K derived: sum of 3 quarters · filed 2021-08-05 | $1.07M derived: sum of 4 quarters · filed 2021-08-05 | ||
| 2020-03-31 | -$6.02M 10-Q · filed 2021-05-05 | $153.00K derived: sum of 2 quarters · filed 2021-05-05 | $1.83M derived: sum of 3 quarters · filed 2021-05-05 | $4.37M derived: sum of 4 quarters · filed 2021-05-05 | ||
| 2019-12-31 | $6.18M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $7.85M derived: sum of 2 quarters · filed 2021-02-25 | $10.40M derived: sum of 3 quarters · filed 2021-02-25 | $9.63M 10-K · filed 2021-02-25 | ||
| 2019-09-30 | $1.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $4.22M derived: sum of 2 quarters · filed 2020-11-05 | $3.45M 10-Q · filed 2020-11-05 | $6.28M derived: sum of 4 quarters · filed 2020-11-05 | ||
| 2019-06-30 | $2.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $1.78M 10-Q · filed 2020-08-06 | $4.60M derived: sum of 3 quarters · filed 2020-08-06 | $7.20M derived: sum of 4 quarters · filed 2020-08-06 | ||
| 2019-03-31 | -$766.00K 10-Q · filed 2020-05-07 | $2.06M derived: sum of 2 quarters · filed 2020-05-07 | $4.66M derived: sum of 3 quarters · filed 2020-05-07 | $6.12M derived: sum of 4 quarters · filed 2020-05-07 | ||
| 2018-12-31 | $2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | $5.43M derived: sum of 2 quarters · filed 2020-02-12 | $6.88M derived: sum of 3 quarters · filed 2020-02-12 | $3.97M 10-K · filed 2020-02-12 | ||
| 2018-09-30 | $2.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $4.06M derived: sum of 2 quarters · filed 2019-11-07 | $1.14M 10-Q · filed 2019-11-07 | $3.91M derived: sum of 4 quarters · filed 2019-11-07 | ||
| 2018-06-30 | $1.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$1.46M 10-Q · filed 2019-08-06 | $1.30M derived: sum of 3 quarters · filed 2019-08-06 | $1.15M derived: sum of 4 quarters · filed 2019-08-06 | ||
| 2018-03-31 | -$2.92M 10-Q · filed 2019-05-09 | -$152.00K derived: sum of 2 quarters · filed 2019-05-09 | -$302.00K derived: sum of 3 quarters · filed 2019-05-09 | $1.05M derived: sum of 4 quarters · filed 2019-05-09 | ||
| 2017-12-31 | $2.76M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $2.61M derived: sum of 2 quarters · filed 2019-03-12 | $3.97M derived: sum of 3 quarters · filed 2019-03-12 | $2.60M 10-K · filed 2019-03-12 | $2.60M 10-K · filed 2018-04-02 | |
| 2017-09-30 | -$150.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $1.21M derived: sum of 2 quarters · filed 2018-11-08 | -$163.00K 10-Q · filed 2018-11-08 | -$166.00K 10-Q · filed 2017-11-07 | $513.00K derived: sum of 4 quarters · filed 2018-11-08 | |
| 2017-06-30 | $1.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$13.00K 10-Q · filed 2018-08-09 | $663.00K derived: sum of 3 quarters · filed 2018-08-09 | $2.96M derived: sum of 4 quarters · filed 2018-08-09 | ||
| 2017-03-31 | -$1.37M 10-Q · filed 2018-05-10 | -$694.00K derived: sum of 2 quarters · filed 2018-05-10 | $1.60M derived: sum of 3 quarters · filed 2018-05-10 | |||
| 2016-12-31 | $676.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $2.97M derived: sum of 2 quarters · filed 2018-04-02 | $2.11M 10-K · filed 2018-04-02 | |||
| 2016-09-30 | $2.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $1.43M 10-Q · filed 2017-11-07 | ||||
| 2016-06-30 | -$866.00K 10-Q · filed 2017-08-31 | |||||
| 2015-12-31 | -$605.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |